BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 27254960)

  • 1. [Lessons from the Hokkaido COPD cohort study].
    Nishimura M; Makita H
    Nihon Rinsho; 2016 May; 74(5):864-8. PubMed ID: 27254960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.
    Oh YM; Jeong BH; Woo SY; Kim SY; Kim H; Lee JH; Lim SY; Rhee CK; Yoo KH; Lee JH; Yoon HK; Sin DD; Lee SD; Kim EK; Park HY;
    Ann Am Thorac Soc; 2015 Jul; 12(7):1005-12. PubMed ID: 26010877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.
    Nagai K; Makita H; Suzuki M; Shimizu K; Konno S; Ito YM; Nishimura M;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():745-57. PubMed ID: 25914531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
    Chiari S; Bassini S; Braghini A; Corda L; Boni E; Tantucci C
    COPD; 2014 Feb; 11(1):33-8. PubMed ID: 24102405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
    Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
    J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity grading of chronic obstructive pulmonary disease: the confounding effect of phenotype and thoracic gas compression.
    Pellegrino R; Crimi E; Gobbi A; Torchio R; Antonelli A; Gulotta C; Baroffio M; Papa GF; Dellacà R; Brusasco V
    J Appl Physiol (1985); 2015 Apr; 118(7):796-802. PubMed ID: 25414244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.
    Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F
    PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients.
    Horita N; Yomota M; Sasaki M; Morita S; Shinkai M; Ishigatsubo Y; Kaneko T
    Clin Respir J; 2014 Apr; 8(2):213-9. PubMed ID: 24131466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD.
    Leivo-Korpela S; Lehtimäki L; Vuolteenaho K; Nieminen R; Kööbi L; Järvenpää R; Kankaanranta H; Saarelainen S; Moilanen E
    Respir Med; 2014 Jan; 108(1):122-8. PubMed ID: 24135487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.
    Sanchez-Salcedo P; Divo M; Casanova C; Pinto-Plata V; de-Torres JP; Cote C; Cabrera C; Zagaceta J; Rodriguez-Roisin R; Zulueta JJ; Marin JM; Celli B
    Eur Respir J; 2014 Aug; 44(2):324-31. PubMed ID: 24696115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study.
    Suzuki M; Makita H; Ito YM; Nagai K; Konno S; Nishimura M;
    Eur Respir J; 2014 May; 43(5):1289-97. PubMed ID: 24232696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.